U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07060196) titled 'The Impact of Artificial Lighting on the Visual Capacity of Patients With Age-Related Macular Degeneration' on June 19.
Brief Summary: Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in the elderly worldwide. The dry, non-exudative form of the disease, although more common, is associated with gradual and significant decline in functional vision. Despite advancements in diagnostic and therapeutic approaches, a targeted intervention that improves the daily functionality of these patients is still lacking. One critical, yet often overlooked, factor that affects daily performance is lighting condi...